GSE4170 provided three stages of CML progression, showing that patients with more aggressive progression had significantly lower GSVA scores of miR-342-5p in CD34+ cells (Fig. 7D, middle panel). Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.